OXTR
MOLECULAR TARGEToxytocin receptor
OXTR (oxytocin receptor) is targeted by 10 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting OXTR
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Oxytocin | 3.89 | 48 |
| 2 | Arginine Vasopressin | 3.09 | 21 |
| 3 | Deamino Arginine Vasopressin | 2.08 | 7 |
| 4 | Calcimycin | 1.10 | 2 |
| 5 | Ornipressin | 1.10 | 2 |
| 6 | Arachidonic Acid | 0.69 | 1 |
| 7 | Astemizole Antihistamine drug now withdrawn from | 0.69 | 1 |
| 8 | Carvedilol | 0.69 | 1 |
| 9 | Niclosamide | 0.69 | 1 |
| 10 | Thioridazine | 0.69 | 1 |
About OXTR as a Drug Target
OXTR (oxytocin receptor) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 10 compounds with documented OXTR interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
OXTR inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.